市場調査レポート

商品コード

1630514

血液凝固検査の世界市場：製品タイプ・用途・検査タイプ・エンドユーザー・地域別の予測 (～2032年)

Blood Coagulation Testing Market Research Report Information by Product, by Application, by Test Type, by End User, and by Region Industry Forecast to 2032

出版日: 2024年12月15日
発行: Market Research Future
ページ情報: 英文 174 Pages
納期: 即納可能

価格

PDF & Excel (Single User License)

USD 4,950 710,671円

レポートPDF、Excelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。

PDF & Excel (Multi User License)

USD 5,950 854,241円

レポートPDF、Excelを同一企業内の最大15名がご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。

PDF & Excel (Enterprise License)

USD 7,250 1,040,882円

レポートPDF、Excelを同一企業内のすべての方がご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDF、Excelの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の血液凝固検査の市場規模は、2023年の45億1,000万米ドル、2024年の48億1,000万米ドルから、予測期間中は6.31％のCAGRで推移し、2032年には78億4,000万米ドルの規模に成長すると予測されています。

出血性疾患の有病率の上昇、参入企業による製品上市の増加などが成長の主な促進要因となっています。一方で、参入企業による自主的な製品回収や凝固分析装置の高コスト性が世界市場の拡大を阻害すると予測されています。それにもかかわらず、出血性疾患に関する政府の積極的な取り組みや世界の高齢者人口の増加が、この業界に利益をもたらすと期待されています。

血友病、フォンヴィレブランド病、その他の関連疾患など、後天性および遺伝性の出血性疾患の有病率が上昇していることが、血液凝固検査市場の成長を促進しています。

地域別インサイト

北米市場は、凝固疾患の有病率の上昇と技術的・革新的な改善により急速に拡大しています。さらに、同地域の確立されたヘルスケアインフラ、技術の進歩、良好な規制環境はすべて、市場の成長に寄与しています。

欧州市場は、強力なヘルスケアインフラと政府の医療イニシアティブおよび財政支援により、第2位の市場シェアを占めています。特に、ドイツの血液凝固検査企業が最大の市場シェアを持つと言われており、フランスの血液凝固検査業者は欧州で最も急成長している市場になると予想されています。

アジア太平洋市場は、2023年から2032年にかけて最も急速に発展すると予測されています。これは、健康管理と早期診断に対する一般市民の意識の高まりと、凝固検査に対する有利な償還政策によるものです。さらに、中国が最大の市場シェアを占め、インドはアジア太平洋地域で最も急速に拡大すると予測されています。

当レポートでは、世界の血液凝固検査の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

LIST OF TABLES

TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 2 GLOBAL BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY REGION, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019-2032 (USD BILLION)
TABLE 5 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR REAGENTS, BY REGION, 2019-2032 (USD BILLION)
TABLE 6 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR TEST KITS, BY REGION, 2019-2032 (USD BILLION)
TABLE 7 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR INSTRUMENTS, BY REGION, 2019-2032 (USD BILLION)
TABLE 8 GLOBAL BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 9 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR ACQUIRED BLEEDING DISORDERS, BY REGION, 2019-2032 (USD BILLION)
TABLE 10 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY REGION, 2019-2032 (USD BILLION)
TABLE 11 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 12 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR HEMOPHILIA, BY REGION, 2019-2032 (USD BILLION)
TABLE 13 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR VON WILLEBRAND DISEASE, BY REGION, 2019-2032 (USD BILLION)
TABLE 14 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD BILLION)
TABLE 15 GLOBAL BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 16 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR PROTHROMBIN TIME TESTING, BY REGION, 2019-2032 (USD BILLION)
TABLE 17 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) TESTING, BY REGION, 2019-2032 (USD BILLION)
TABLE 18 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR FIBRINOGEN TESTING, BY REGION, 2019-2032 (USD BILLION)
TABLE 19 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR ACTIVATED CLOTTING TIME TESTING, BY REGION, 2019-2032 (USD BILLION)
TABLE 20 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR PLATELET FUNCTION TESTS, BY REGION, 2019-2032 (USD BILLION)
TABLE 21 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD BILLION)
TABLE 22 GLOBAL BLOOD COAGULATION TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 23 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR HOSPITALS AND CLINICS, BY REGION, 2019-2032 (USD BILLION)
TABLE 24 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR DIAGNOSTIC CENTERS, BY REGION, 2019-2032 (USD BILLION)
TABLE 25 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR AMBULATORY CARE CENTERS, BY REGION, 2019-2032 (USD BILLION)
TABLE 26 GLOBAL BLOOD COAGULATION TESTING MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD BILLION)
TABLE 27 GLOBAL BLOOD COAGULATION TESTING MARKET, BY REGION, 2019-2032 (USD BILLION)
TABLE 28 NORTH AMERICA: BLOOD COAGULATION TESTING MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
TABLE 29 NORTH AMERICA: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 30 NORTH AMERICA: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019-2032 (USD BILLION)
TABLE 31 NORTH AMERICA: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 32 NORTH AMERICA: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 33 NORTH AMERICA: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 34 NORTH AMERICA: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 35 US: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 36 US: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019-2032 (USD BILLION)
TABLE 37 US: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 38 US: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 39 US: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 40 US: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 41 CANADA: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 42 CANADA: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019-2032 (USD BILLION)
TABLE 43 CANADA: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 44 CANADA: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 45 CANADA: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 46 CANADA: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 47 EUROPE: BLOOD COAGULATION TESTING MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
TABLE 48 EUROPE: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 49 EUROPE: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019-2032 (METRIC TON)
TABLE 50 EUROPE: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 51 EUROPE: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 52 EUROPE: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 53 EUROPE: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 54 GERMANY: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 55 GERMANY: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019-2032 (METRIC TON)
TABLE 56 GERMANY: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 57 GERMANY: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 58 GERMANY: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 59 GERMANY: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 60 FRANCE: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 61 FRANCE: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019-2032 (METRIC TON)
TABLE 62 FRANCE: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 63 FRANCE: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 64 FRANCE: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 65 FRANCE: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 66 UK: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 67 UK: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019-2032 (METRIC TON)
TABLE 68 UK: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 69 UK: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 70 UK: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 71 UK: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 72 ITALY: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 73 ITALY: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019-2032 (METRIC TON)
TABLE 74 ITALY: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 75 ITALY: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 76 ITALY: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 77 ITALY: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 78 SPAIN: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 79 SPAIN: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019-2032 (METRIC TON)
TABLE 80 SPAIN: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 81 SPAIN: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 82 SPAIN: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 83 SPAIN: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 84 REST OF EUROPE: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 85 REST OF EUROPE: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019-2032 (METRIC TON)
TABLE 86 REST OF EUROPE: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 87 REST OF EUROPE: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 88 REST OF EUROPE: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 89 REST OF EUROPE: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 90 ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
TABLE 91 ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 92 ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019-2032 (METRIC TON)
TABLE 93 ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 94 ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 95 ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 96 ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 97 CHINA: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 98 CHINA: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019-2032 (METRIC TON)
TABLE 99 CHINA: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 100 CHINA: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 101 CHINA: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 102 CHINA: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 103 INDIA: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 104 INDIA: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019-2032 (METRIC TON)
TABLE 105 INDIA: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 106 INDIA: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 107 INDIA: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 108 INDIA: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 109 JAPAN: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 110 JAPAN: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019-2032 (METRIC TON)
TABLE 111 JAPAN: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 112 JAPAN: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 113 JAPAN: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 114 JAPAN: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 115 AUSTRALIA: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 116 AUSTRALIA: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019-2032 (METRIC TON)
TABLE 117 AUSTRALIA: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 118 AUSTRALIA: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 119 AUSTRALIA: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 120 AUSTRALIA: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 121 SOUTH KOREA: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 122 SOUTH KOREA: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019-2032 (METRIC TON)
TABLE 123 SOUTH KOREA: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 124 SOUTH KOREA: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 125 SOUTH KOREA: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 126 SOUTH KOREA: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 127 REST OF ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 128 REST OF ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019-2032 (METRIC TON)
TABLE 129 REST OF ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 130 REST OF ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDERS, BY TYPE, 2019-2032 (USD BILLION)
TABLE 131 REST OF ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 132 REST OF ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 133 REST OF THE WORLD BLOOD COAGULATION TESTING MARKET, BY REGION, 2019-2032 (USD BILLION)
TABLE 134 REST OF THE WORLD: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 135 REST OF THE WORLD: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019-2032 (USD BILLION)
TABLE 136 REST OF THE WORLD: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 137 REST OF THE WORLD: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDER, BY TYPE 2019-2032 (USD BILLION)
TABLE 138 REST OF THE WORLD: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE 2019-2032 (USD BILLION)
TABLE 139 REST OF THE WORLD: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 140 MIDDLE EAST: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 141 MIDDLE EAST: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019-2032 (USD BILLION)
TABLE 142 MIDDLE EAST: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 143 MIDDLE EAST: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDER, BY TYPE 2019-2032 (USD BILLION)
TABLE 144 MIDDLE EAST: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE 2019-2032 (USD BILLION)
TABLE 145 MIDDLE EAST: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 146 AFRICA: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 147 AFRICA: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019-2032 (USD BILLION)
TABLE 148 AFRICA: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 149 AFRICA: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDER, BY TYPE 2019-2032 (USD BILLION)
TABLE 150 AFRICA: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE 2019-2032 (USD BILLION)
TABLE 151 AFRICA: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 152 LATIN AMERICA: BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 153 LATIN AMERICA: BLOOD COAGULATION TESTING MARKET, FOR CONSUMABLES, BY TYPE, 2019-2032 (USD BILLION)
TABLE 154 LATIN AMERICA: BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 155 LATIN AMERICA: BLOOD COAGULATION TESTING MARKET, FOR INHERITED BLEEDING DISORDER, BY TYPE 2019-2032 (USD BILLION)
TABLE 156 LATIN AMERICA: BLOOD COAGULATION TESTING MARKET, BY TEST TYPE 2019-2032 (USD BILLION)
TABLE 157 LATIN AMERICA: BLOOD COAGULATION TESTING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 158 EXPANSION
TABLE 159 AGREEMENT
TABLE 160 PRODUCT LAUNCH
TABLE 161 APPROVAL
TABLE 162 ACQUISITION
TABLE 163 PRODUCT RECOGNISTION
TABLE 164 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
TABLE 165 F. HOFFMANN-LA ROCHE LTD.: KEY DEVELOPMENTS
TABLE 166 MICROPOINT BIOTECHNOLOGIES CO., LTD.: PRODUCTS OFFERED
TABLE 167 HEMOSONICS, LLC: PRODUCTS OFFERED
TABLE 168 HEMOSONICS, LLC: KEY DEVELOPMENTS
TABLE 169 HELENA LABORATORIES CORPORATION: PRODUCTS OFFERED
TABLE 170 SYSMEX CORPORATION: PRODUCTS OFFERED
TABLE 171 SYSMEX CORPORATION: KEY DEVELOPMENTS
TABLE 172 WERFEN: PRODUCTS OFFERED
TABLE 173 WERFEN: KEY DEVELOPMENTS
TABLE 174 MERIL LIFE SCIENCES PVT. LTD.: PRODUCTS OFFERED
TABLE 175 THERMO FISHER SCIENTIFIC, INC.: PRODUCTS OFFERED
TABLE 176 SIEMENS HEALTHINEERS AG: PRODUCT OFFERED
TABLE 177 SIEMENS HEALTHINEERS: KEY DEVELOPMENTS

LIST OF FIGURES

FIGURE 1 GLOBAL BLOOD COAGULATION TESTING MARKET: STRUCTURE
FIGURE 2 GLOBAL BLOOD COAGULATION TESTING MARKET: MARKET GROWTH FACTOR ANALYSIS (2024-2032)
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032)
FIGURE 5 NUMBER OF PEOPLE AGED 60 YEARS OR OVER IN ASIA-PACIFIC, BY SUBREGION, 2022, 2030 AND
FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: GLOBAL BLOOD COAGULATION TESTING MARKET
FIGURE 7 GLOBAL BLOOD COAGULATION TESTING MARKET, 2023 & 2032 (USD BILLION)
FIGURE 8 GLOBAL BLOOD COAGULATION TESTING MARKET, BY PRODUCT, 2023 & 2032 (USD BILLION)
FIGURE 9 GLOBAL BLOOD COAGULATION TESTING MARKET SHARE (%), BY PRODUCT,
FIGURE 10 GLOBAL BLOOD COAGULATION TESTING MARKET, APPLICATION, 2023 & 2032 (USD BILLION)
FIGURE 11 GLOBAL BLOOD COAGULATION TESTING MARKET, BY APPLICATION, 2023 & 2032 (USD BILLION)
FIGURE 12 GLOBAL BLOOD COAGULATION TESTING MARKET SHARE (%), BY APPLICATION,
FIGURE 13 GLOBAL BLOOD COAGULATION TESTING MARKET, TEST TYPE, 2023 & 2032 (USD BILLION)
FIGURE 14 GLOBAL BLOOD COAGULATION TESTING MARKET, BY TEST TYPE, 2023 & 2032 (USD BILLION)
FIGURE 15 GLOBAL BLOOD COAGULATION TESTING MARKET SHARE (%), BY TEST TYPE,
FIGURE 16 GLOBAL BLOOD COAGULATION TESTING MARKET, END USER, 2023 & 2032 (USD BILLION)
FIGURE 17 GLOBAL BLOOD COAGULATION TESTING MARKET, BY END USER, 2023 & 2032 (USD BILLION)
FIGURE 18 GLOBAL BLOOD COAGULATION TESTING MARKET SHARE (%), BY END USER,
FIGURE 19 GLOBAL BLOOD COAGULATION TESTING MARKET, BY REGION, 2023 & 2032 (USD BILLION)
FIGURE 20 GLOBAL BLOOD COAGULATION TESTING MARKET SHARE (%), BY REGION,
FIGURE 21 NORTH AMERICA MARKET ANALYSIS: BLOOD COAGULATION TESTING MARKET, 2019-2032
FIGURE 22 NORTH AMERICA: BLOOD COAGULATION TESTING MARKET, BY COUNTRY, 2023 & 2032 (USD BILLION)
FIGURE 23 NORTH AMERICA: BLOOD COAGULATION TESTING MARKET SHARE (%), BY COUNTRY,
FIGURE 24 EUROPE MARKET ANALYSIS: BLOOD COAGULATION TESTING MARKET, 2019-2032 (USD BILLION)
FIGURE 25 EUROPE: BLOOD COAGULATION TESTING MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD BILLION)
FIGURE 26 EUROPE: BLOOD COAGULATION TESTING MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 27 ASIA-PACIFIC MARKET ANALYSIS: BLOOD COAGULATION TESTING MARKET, 2019-2032 (USD BILLION)
FIGURE 28 ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD BILLION)
FIGURE 29 ASIA-PACIFIC: BLOOD COAGULATION TESTING MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 30 REST OF THE WORLD MARKET ANALYSIS: BLOOD COAGULATION TESTING MARKET, 2019-2032 (USD BILLION)
FIGURE 31 REST OF THE WORLD: BLOOD COAGULATION TESTING MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD BILLION)
FIGURE 32 REST OF THE WORLD: BLOOD COAGULATION TESTING MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 33 GLOBAL BLOOD COAGULATION TESTING MARKET PLAYERS: COMPETITIVE ANALYSIS,
FIGURE 34 COMPETITOR DASHBOARD: GLOBAL BLOOD COAGULATION TESTING MARKET
FIGURE 35 F. HOFFMANN-LA ROCHE LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 F. HOFFMANN-LA ROCHE LTD.: SWOT ANALYSIS
FIGURE 37 SYSMEX CORPORATION: SWOT ANALYSIS
FIGURE 38 SYSMEX CORPORATION: SWOT ANALYSIS
FIGURE 39 WERFEN: SWOT ANALYSIS
FIGURE 40 THERMO FISHER SCIENTIFIC, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 41 THERMO FISHER SCIENTIFIC, INC.: SWOT ANALYSIS
FIGURE 42 SIEMENS HEALTHINEERS AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 43 SIEMENS HEALTHINEERS AG: SWOT ANALYSI

Product Code: MRFR/LS/0464-CR

Blood Coagulation Testing Market Research Report Information by Product (Consumables and Instruments), by Application (Acquired Bleeding Disorders and Inherited Bleeding Disorders), by Test Type (Prothrombin Time Testing, Activated Partial Thromboplastin Time (aPTT) Testing, Fibrinogen Testing, Activated Clotting Time Testing, Platelet Function Tests, and Others), by End User (Hospitals and Clinics, Diagnostic Centers, Ambulatory Care Centers, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World Industry Forecast to 2032

Market Overview

The Blood Coagulation Testing Market was valued at USD 4.51 billion in 2023. The Blood Coagulation Testing Market is expected to increase from USD 4.81 billion in 2024 to USD 7.84 billion by 2032, with a compound annual growth rate (CAGR) of 6.31% over the forecast period (2024-2032).

The rising prevalence of blood-acquired bleeding disorders, as well as increased product launches by market players in the blood coagulation testing market, are the primary drivers of growth. However, voluntary product recalls by market participants, as well as the high cost of coagulation analyzers, are projected to impede worldwide market expansion. Nonetheless, favorable government initiatives related to bleeding disorders and an increasing geriatric population around the world are expected to generate profitable potential for the industry.

The rising prevalence of both acquired and hereditary bleeding diseases, such as hemophilia, von Willebrand Disease, and other related ailments, is driving the growth of the blood coagulation testing market.

Market Segment insights

Consumables and instruments make up the product sector of the Blood Coagulation Testing Market.

The Blood Coagulation Testing Market is segmented by application, which includes both acquired and inherited bleeding diseases.

The Blood Coagulation Testing Market is divided into test types, which include prothrombin time testing, activated partial thromboplastin time (aPTT) testing, fibrinogen testing, activated clotting time testing, platelet function tests, and others.

End-user segments in the Blood Coagulation Testing Market comprise hospitals and clinics, diagnostic centers, ambulatory care centers, and others.

Regional insights

The study divides the market into four regions: North America, Europe, Asia-Pacific, and the rest of the world. The North American Blood Coagulation Testing market is expanding rapidly, owing to the rising prevalence of coagulation diseases as well as technological and innovative improvements. Furthermore, the region's well-established healthcare infrastructure, technological advancements, and favorable regulatory environment all contribute to the market's growth.

The European Blood Coagulation Testing market accounted for the second-largest market share, owing to strong healthcare infrastructure and supported government health initiatives and financing. Furthermore, the Germany Blood Coagulation Testing supplier is said to have the greatest market share, while the France Blood Coagulation Testing provider is expected to be the fastest growing market in Europe.

The Asia-Pacific Blood Coagulation Testing market is predicted to develop the fastest from 2023 to 2032, owing to increased public awareness of health management and early diagnosis, as well as favorable reimbursement policies for coagulation tests. Furthermore, China Blood Coagulation Testing accounted for the greatest market share, while India Blood Coagulation Testing is expected to be the fastest expanding market in the Asia Pacific region.

Major Players

Hoffmann-La Roche Ltd., Abbott, Siemens Healthcare, Thermo Fisher Scientific Inc., Sysmex Corporation, Werfen, HemoSonics, LLC, Micropoint Biotechnologies Co., Ltd., Helena Laboratories, and Meril Life Sciences Pvt. Ltd. are among the key players in the Blood Coagulation Testing market.

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

3.1 OVERVIEW
3.2 DATA FLOW
- 3.2.1 DATA MINING PROCESS
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
- 3.4.1 SECONDARY RESEARCH DATA FLOW:
3.5 PRIMARY RESEARCH:
- 3.5.1 PRIMARY RESEARCH DATA FLOW:
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
- 3.6.1 REVENUE ANALYSIS APPROACH
3.7 DATA FORECASTING
- 3.7.1 DATA FORECASTING TYPE
3.8 DATA MODELING
- 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
- 3.8.2 DATA MODELING:
3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

4.1 INTRODUCTION
4.2 DRIVERS
- 4.2.1 INCREASING INCIDENCES OF BLOOD ACQUIRED BLEEDING DISORDERS
- 4.2.2 RISING PRODUCT LAUNCH BY MARKET PLAYERS
4.3 RESTRAINTS
- 4.3.1 VOLUNTARY PRODUCT RECALL BY MARKET PLAYERS
- 4.3.2 HIGH COST ASSOCIATED WITH COAGULATION ANALYZER
4.4 OPPORTUNITY
- 4.4.1 FAVOURABLE GOVERNMENT INITIATIVES ASSOCIATED WITH BLEEDING DISORDERS
- 4.4.2 GROWING GERIATRIC POPULATION ACROSS THE GLOBE

5 MARKET FACTOR ANALYSIS

5.1 PORTER'S FIVE FORCES MODEL
- 5.1.1 THREAT OF NEW ENTRANTS
- 5.1.2 BARGAINING POWER OF SUPPLIERS
- 5.1.3 THREAT OF SUBSTITUTES
- 5.1.4 BARGAINING POWER OF BUYERS
- 5.1.5 INTENSITY OF RIVALRY
5.2 IMPACT OF COVID-19 ON THE GLOBAL BLOOD COAGULATION TESTING MARKET

6 GLOBAL BLOOD COAGULATION TESTING MARKET, BY PRODUCT

6.1 OVERVIEW
6.2 CONSUMABLES
- 6.2.1 REAGENTS
- 6.2.2 TEST KITS
6.3 INSTRUMENTS

7 GLOBAL BLOOD COAGULATION TESTING MARKET, BY APPLICATION

7.1 OVERVIEW
7.2 ACQUIRED BLEEDING DISORDERS
7.3 INHERITED BLEEDING DISORDERS
- 7.3.1 HEMOPHILIA
- 7.3.2 VON WILLEBRAND DISEASE
- 7.3.3 OTHERS

8 GLOBAL BLOOD COAGULATION TESTING MARKET, BY TEST TYPE

8.1 OVERVIEW
8.2 PROTHROMBIN TIME TESTING
8.3 ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) TESTING
8.4 FIBRINOGEN TESTING
8.5 ACTIVATED CLOTTING TIME TESTING
8.6 PLATELET FUNCTION TESTS
8.7 OTHERS

9 GLOBAL BLOOD COAGULATION TESTING MARKET, BY END USER

9.1 OVERVIEW
9.2 HOSPITALS AND CLINICS
9.3 DIAGNOSTIC CENTERS
9.4 AMBULATORY CARE CENTERS
9.5 OTHERS

10 GLOBAL BLOOD COAGULATION TESTING MARKET, BY REGION

10.1 OVERVIEW
10.2 NORTH AMERICA
- 10.2.1 US
- 10.2.2 CANADA
10.3 EUROPE
- 10.3.1 GERMANY
- 10.3.2 FRANCE
- 10.3.3 UK
- 10.3.4 ITALY
- 10.3.5 SPAIN
- 10.3.6 REST OF EUROPE
10.4 ASIA-PACIFIC
- 10.4.1 CHINA
- 10.4.2 INDIA
- 10.4.3 JAPAN
- 10.4.4 AUSTRALIA
- 10.4.5 SOUTH KOREA
- 10.4.6 REST OF ASIA-PACIFIC
10.5 REST OF THE WORLD
- 10.5.1 MIDDLE EAST
- 10.5.2 AFRICA
- 10.5.3 LATIN AMERICA

11 COMPETITIVE LANDSCAPE

11.1 INTRODUCTION
11.2 MARKET SHARE ANALYSIS,
11.3 COMPETITOR DASHBOARD
11.4 PUBLIC PLAYERS STOCK SUMMARY
11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 11.6.1 EXPANSION
- 11.6.2 AGREEMENT
- 11.6.3 PRODUCT LAUNCH
- 11.6.4 APPROVAL
- 11.6.5 AQUISITION
- 11.6.6 PRODUCT RECOGNITION

12 COMPANY PROFILES

12.1 F. HOFFMANN-LA ROCHE LTD.
- 12.1.1 COMPANY OVERVIEW
- 12.1.2 FINANCIAL OVERVIEW
- 12.1.3 PRODUCTS OFFERED
- 12.1.4 KEY DEVELOPMENTS
- 12.1.5 SWOT ANALYSIS
- 12.1.6 KEY STRATEGIES
12.2 MICROPOINT BIOTECHNOLOGIES CO., LTD.
- 12.2.1 COMPANY OVERVIEW
- 12.2.2 FINANCIAL OVERVIEW
- 12.2.3 PRODUCTS OFFERED
- 12.2.4 KEY DEVELOPMENTS
- 12.2.5 KEY STRATEGIES
12.3 HOMOSONICS LLC
- 12.3.1 COMPANY OVERVIEW
- 12.3.2 FINANCIAL OVERVIEW
- 12.3.3 PRODUCTS OFFERED
- 12.3.4 KEY DEVELOPMENTS
- 12.3.5 KEY STRATEGIES
12.4 HELENA LABORATORIES CORPORATION
- 12.4.1 COMPANY OVERVIEW
- 12.4.2 FINANCIAL OVERVIEW
- 12.4.3 PRODUCTS OFFERED
- 12.4.4 KEY DEVELOPMENTS
- 12.4.5 KEY STRATEGIES
12.5 SYSMEX CORPORATION
- 12.5.1 COMPANY OVERVIEW
- 12.5.2 FINANCIAL OVERVIEW
- 12.5.3 PRODUCTS OFFERED
- 12.5.4 KEY DEVELOPMENTS
- 12.5.5 SWOT ANALYSIS
- 12.5.6 KEY STRATEGIES
12.6 WERFEN
- 12.6.1 COMPANY OVERVIEW
- 12.6.2 FINANCIAL OVERVIEW
- 12.6.3 PRODUCTS OFFERED
- 12.6.4 KEY DEVELOPMENTS
- 12.6.5 KEY STRATEGIES
12.7 MERIL LIFE SCIENCES PVT. LTD.
- 12.7.1 COMPANY OVERVIEW
- 12.7.2 FINANCIAL OVERVIEW
- 12.7.3 PRODUCTS OFFERED
- 12.7.4 KEY DEVELOPMENTS
- 12.7.5 KEY STRATEGIES
12.8 THERMO FISHER SCIENTIFIC, INC.
- 12.8.1 COMPANY OVERVIEW
- 12.8.2 FINANCIAL OVERVIEW
- 12.8.3 PRODUCTS OFFERED
- 12.8.4 KEY DEVELOPMENTS
- 12.8.5 SWOT ANALYSIS
- 12.8.6 KEY STRATEGIES
12.9 SIEMENS HEALTHINEERS AG
- 12.9.1 COMPANY OVERVIEW
- 12.9.2 FINANCIAL OVERVIEW
- 12.9.3 PROUDCTS OFFERED
- 12.9.4 KEY DEVELOPMENTS
- 12.9.5 SWOT ANALYSIS
- 12.9.6 KEY STRATEGIES

血液凝固検査の世界市場：製品タイプ・用途・検査タイプ・エンドユーザー・地域別の予測 (～2032年)

Blood Coagulation Testing Market Research Report Information by Product, by Application, by Test Type, by End User, and by Region Industry Forecast to 2032

目次

第1章エグゼクティブサマリー

第2章市場概要

第3章調査手法

第4章市場力学

第5章市場要因分析

第6章世界の血液凝固検査市場：製品別

第7章世界の血液凝固検査市場：用途別

第8章世界の血液凝固検査市場：検査タイプ別

第9章世界の血液凝固検査市場：エンドユーザー別

第10章世界の血液凝固検査市場：地域別

第11章競合情勢

第12章企業プロファイル

第13章データの引用

LIST OF TABLES

LIST OF FIGURES

Market Overview

Major Players

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

3 RESEARCH METHODOLOGY

4 MARKET DYNAMICS

5 MARKET FACTOR ANALYSIS

6 GLOBAL BLOOD COAGULATION TESTING MARKET, BY PRODUCT

7 GLOBAL BLOOD COAGULATION TESTING MARKET, BY APPLICATION

8 GLOBAL BLOOD COAGULATION TESTING MARKET, BY TEST TYPE

9 GLOBAL BLOOD COAGULATION TESTING MARKET, BY END USER

10 GLOBAL BLOOD COAGULATION TESTING MARKET, BY REGION

11 COMPETITIVE LANDSCAPE

12 COMPANY PROFILES

13 DATA CITATIONS

血液凝固検査の世界市場：製品タイプ・用途・検査タイプ・エンドユーザー・地域別の予測 (～2032年)

Blood Coagulation Testing Market Research Report Information by Product, by Application, by Test Type, by End User, and by Region Industry Forecast to 2032

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 調査手法

第4章 市場力学

第5章 市場要因分析

第6章 世界の血液凝固検査市場：製品別

第7章 世界の血液凝固検査市場：用途別

第8章 世界の血液凝固検査市場：検査タイプ別

第9章 世界の血液凝固検査市場：エンドユーザー別

第10章 世界の血液凝固検査市場：地域別

第11章 競合情勢

第12章 企業プロファイル

第13章 データの引用

LIST OF TABLES

LIST OF FIGURES

Market Overview

Major Players

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

3 RESEARCH METHODOLOGY

4 MARKET DYNAMICS

5 MARKET FACTOR ANALYSIS

6 GLOBAL BLOOD COAGULATION TESTING MARKET, BY PRODUCT

7 GLOBAL BLOOD COAGULATION TESTING MARKET, BY APPLICATION

8 GLOBAL BLOOD COAGULATION TESTING MARKET, BY TEST TYPE

9 GLOBAL BLOOD COAGULATION TESTING MARKET, BY END USER

10 GLOBAL BLOOD COAGULATION TESTING MARKET, BY REGION

11 COMPETITIVE LANDSCAPE

12 COMPANY PROFILES

13 DATA CITATIONS

第1章エグゼクティブサマリー

第2章市場概要

第3章調査手法

第4章市場力学

第5章市場要因分析

第6章世界の血液凝固検査市場：製品別

第7章世界の血液凝固検査市場：用途別

第8章世界の血液凝固検査市場：検査タイプ別

第9章世界の血液凝固検査市場：エンドユーザー別

第10章世界の血液凝固検査市場：地域別

第11章競合情勢

第12章企業プロファイル

第13章データの引用